Ubiquitin, proteasomes and proteolytic mechanisms activated by kidney disease
about
Current status of bicarbonate in CKDActivation of the ubiquitin-proteasome system in doxorubicin cardiomyopathy.The ubiquitin-proteasome system and assays to determine responses to inhibitors.Alterations in the ubiquitin proteasome system in persistent but not reversible proteinuric diseasesInflammation and cachexia in chronic kidney disease.Protein phosphatase 2C-alpha knockdown reduces angiotensin II-mediated skeletal muscle wasting via restoration of mitochondrial recycling and functionProtein-energy wasting and mortality in chronic kidney disease.Angiotensin II upregulates protein phosphatase 2Cα and inhibits AMP-activated protein kinase signaling and energy balance leading to skeletal muscle wastingInsulin sensitivity of muscle protein metabolism is altered in patients with chronic kidney disease and metabolic acidosis.Ubiquitin degradation with its substrate, or as a monomer in a ubiquitination-independent mode, provides clues to proteasome regulation.Omega-3 fatty acid supplementation in advanced kidney disease.The role of the ubiquitin-proteasome system in kidney diseases.Physiological functions and clinical implications of the N-end rule pathway.Combined treatment of carfilzomib and z-VAD-fmk inhibits skeletal proteolysis and apoptosis and ameliorates cancer cachexia.Malnutrition in Chronic Kidney Disease.
P2860
Q27015082-5C9E7F01-3E07-4152-8A74-0C1F62830679Q33699632-050E0015-52F2-49EA-B1DE-97D7FC4FA9E7Q34347848-8A5B2917-517C-4878-AF88-BC1E6BF1821FQ34427577-DE4559B1-E047-4E12-B44B-4DA280E096E5Q34616311-4F15CFDD-8EB1-4A7D-8974-BC4CBE9144A4Q35011884-FF39FA63-AE37-4384-8518-E9DD2AA38523Q35024794-59CC1EF5-7787-4C22-8A08-B8C93D8E4303Q35240148-5144AE4D-08D1-4753-AF69-0E1EA0FCF9B0Q36369287-66B7F7A5-862B-49D9-BCE7-366AF3009B4BQ37274327-580BF2E3-2BDF-4711-9483-625CBEADCAC6Q37779352-F14041E9-0F2C-4D7F-B52D-58639F2BF9CCQ38017592-72B0B163-6CCF-42FB-A02F-8DCED9F961E2Q38919056-40A30F26-DCC8-407C-A831-35F14658BBF2Q53590006-CFB00DA8-F092-420C-9ADD-0513CCFBEB48Q55512591-38FD1010-0FB3-4BEF-A977-38E6093069F2
P2860
Ubiquitin, proteasomes and proteolytic mechanisms activated by kidney disease
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ubiquitin, proteasomes and proteolytic mechanisms activated by kidney disease
@en
Ubiquitin, proteasomes and proteolytic mechanisms activated by kidney disease.
@nl
type
label
Ubiquitin, proteasomes and proteolytic mechanisms activated by kidney disease
@en
Ubiquitin, proteasomes and proteolytic mechanisms activated by kidney disease.
@nl
prefLabel
Ubiquitin, proteasomes and proteolytic mechanisms activated by kidney disease
@en
Ubiquitin, proteasomes and proteolytic mechanisms activated by kidney disease.
@nl
P2860
P1476
Ubiquitin, proteasomes and proteolytic mechanisms activated by kidney disease
@en
P2093
William E Mitch
P2860
P304
P356
10.1016/J.BBADIS.2008.07.007
P407
P577
2008-08-05T00:00:00Z